Selank
Selank (TP-7)
A synthetic analog of tuftsin with anxiolytic and nootropic properties. Modulates GABA and serotonin systems to reduce anxiety without sedation.
FDA Status
Not FDA-approved in US — approved in Russia as anxiolytic
Typical Dose
200–400 mcg intranasal, evening
Evidence Grade
BLimited clinical + robust preclinical evidence
Clinics Indexed
72 providers have offered Selank in our tracked directory.
Key Reported Benefits
- ✓Anxiety reduction
- ✓Stress resilience
- ✓Cognitive clarity
- ✓Immune modulation
Benefits listed reflect commonly reported effects from clinical trials and practitioner use. Individual response varies. Evidence-grade B indicates limited clinical + robust preclinical evidence.
Regulatory & Safety Context
FDA status: Not FDA-approved in US — approved in Russia as anxiolytic
This page is for educational purposes only and does not constitute medical advice. Peptide use outside of an FDA-approved indication should be discussed with a licensed medical professional. Source quality, cold-chain storage, and injection hygiene all materially affect safety outcomes.